EWALL-RH-01
Laufzeit: 01.01.2009 - 31.12.2014
imported
Kurzfassung
Induction and consolidation therapy with Dasatinib in combination with chemotherapy in patients aged 55 years and over with Ph+ chromosome (or bcr-abl+) acute lymphoblastic leukemia
